Zai Lab Limited

20.06 USD
+0.06 (+0.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Zai Lab Limited stock is down -6.91% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 June’s closed higher than May. In the last 4 Unusual Options Trades, there were 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 May 18:26 17 Jan, 2025 30.00 CALL 285 3
13 May 16:07 21 Jun, 2024 20.00 CALL 99 154
14 May 16:19 21 Jun, 2024 20.00 CALL 100 139
14 May 16:52 21 Jun, 2024 20.00 CALL 100 139

About Zai Lab Limited

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia. It also develops Odronextamab, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer